P71 Inpatient and Outpatient Medical Costs, Hospitalizations, and Length of Stay Associated with Adherence to Non-cycled Oral Antineoplastics Among Oncology Patients

Abstract

10.1016/j.jaip.2021.12.026Increasing utilization of non-cycled antineoplastic therapies for a variety of cancers has generated interest in applying a proportion of days covered (PDC) adherence metric, and examining costs and health outcomes associated with adherent PDC (≥80%).